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Comparison of hypertension control  
in patients with diabetes and hypertension 
and patients with hypertension without  
diabetes depending on the stage  
of chronic kidney disease
ABSTRACT
Diabetes and hypertension are plagues of the begin-
ning of the 21st century. Both of these conditions lead 
to significant deterioration in quality of life and reduc-
tion of patient’s life expectancy. The aim of the work 
was to answer the questions: what is the all day, daily 
and night systolic and diastolic blood pressure in pa-
tients with hypertension and in patients with diabetes 
and hypertension, depending on the stage of chronic 
kidney disease, and whether there are significant dif-
ferences in the control of day and night systolic and 
diastolic blood pressure between the patients with 
diabetes mellitus and hypertension. 300 patients have 
been admitted to the Department of Internal Diseases, 
Diabetology and Nephrology due to hypertension 
decompensation. In the first place all subjects were 
divided into two groups: the ones with diabetes and 
hypertension and patients with hypertension but with-
out diabetes. Afterwards the patients were divided in 
5 subgroups depending on the stage of chronic kidney 
disease. It was shown that patients with diabetes and 
hypertension are significantly less likely to have their 
blood pressure controlled properly (24 hours a day, 
during the day and at night) in relation to patients 
with hypertension without diabetes and that, with 
increased renal failure, diabetes and hypertension and 
hypertensive patients without diabetes do not have 
good blood pressure control, especially for diabetics 
and hypertension. (Clin Diabetol 2017; 6, 3: 81–89)
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Introduction
In Poland, about 3.1 million people are patients suf-
fering from diabetes and over 10 million patients suf-
fering from hypertension [1]. Many patients suffering 
from diabetes are also diagnosed with hypertension. 
Both diabetes and hypertension cause a significant de-
terioration in the quality of life as well as the reduction 
of a patient’s life expectancy [2, 3]. It is only the good 
control of diabetes and hypertension that may prevent 
or postpone the period of occurrence of complication 
development in these patients [4–7]. In patients with 
diabetes and without it, together with the progressive 
development of the disease there is deterioration in the 
hypertension control [8]. Treatment of these patients 
should be more aggressive, namely it should require 
the application of several drugs of various mechanisms 
of action [9, 10]. 
With regard to the above, it was decided to find 
the answer to the following questions: 
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1. What is the state of systolic and diastolic blood 
pressure, over the period of 24 hours, during the 
day and at night in patients with hypertension 
and in patients with diabetes and hypertension?
2. What is the state of systolic and diastolic blood 
pressure over the period of 24 hours, during the 
day and at night in patients with hypertension 
and in patients with diabetes and hypertension 
depending on the stage of chronic kidney dis-
ease?
3. If there are any significant differences in control 
of the systolic and diastolic blood pressure during 
the day and at night between the patients with 
hypertension and patients with diabetes and hy-
pertension?
Material and methods
In order to obtain an answers to the questions 
raised, further 300 patients were admitted to the 
Department of Internal Diseases, Diabetology and 
Nephrology in Zabrze, Medical University of Silesia in 
Katowice. The reason for the admission was either the 
uncontrolled hypertension and diabetes or uncontrolled 
hypertension without diabetes, within the period of 
1.01.2013–31.12.2013. Basic tests and the assessment 
of the daily blood pressure profile were performed 
among the admitted patients. The average age of the 
study subjects was 61 ± 15 years, average height 1.66 
± 0.09 metres, average body weight 84.20 ± 18 kg 
and the average BMI 31.19 ± 8.23 kg/m2. The average 
duration of hypertension was 14.06 ± 8.74 years. On 
admission, the average systolic blood pressure was 150 
± 9 mm Hg and the average diastolic blood pressure 
was 88 ± 18 mm Hg. 
In the first place all subjects were divided into two 
groups of patients : with diabetes and hypertension 
and patients with hypertension but without diabetes.
188 patients were assigned to the group of pa-
tients with diabetes and hypertension. The average 
age of the study subjects was 64.16 ± 12 years, aver-
age height 1.64 ± 0.09 metres, average body weight 
86.54 ± 19.49 kg, BMI 32.18 ± 9.15 kg/m2. The aver-
age duration of diabetes was 11.41 ± 8.69 years, and 
of hypertension was 13.01 ± 8.2. On admission the 
average systolic blood pressure was 52 ± 26 mm Hg, 
and the average diastolic blood pressure was 86 ± 
15 mm Hg. 112 patients were assigned to the group 
with hypertension without diabetes. The average age 
of the study subjects was 57.41 ± 17.08 years, aver-
age height 1.64 ± 0.09 metres, average body weight 
78.40 ± 14.78 kg, BMI 29.03 ± 5.22 kg/m2. The average 
duration of hypertension was 12.47 ± 8.29 years. On 
admission, the average systolic blood pressure was 149 
± 25 mm Hg, and the average diastolic blood pressure 
was 90 ± 24 mm Hg. 
Patients with diabetes and hypertension in relation 
to patients with diabetes without hypertension were: 
1. significantly older, 2. had considerably greater body 
weight and 3. had substantially higher BMI. There were 
no differentiations in the average duration time of 
hypertension and systolic and diastolic blood pressure 
between the patients with diabetes and hypertension 
and patients with hypertension and without diabetes.
Subsequently the whole group was divided into 5 
subgroups depending on the stage of chronic kidney 
disease (CKD), which included respective study subjects.
58 patients were assigned to stage I of CKD group with 
eGFR > 90 mL/min/1.73 m2. 68 patients were assigned to 
stage II of CKD group with eGFR 60–90 mL/min/1.73 m2. 
108 patients were assigned to stage III of CKD group 
with eGFR 30–59 mL/min/1.73 m2. 52 patients were as-
signed to stage IV of CKD group with eGFR 15–29 mL/ 
/min/1.73 m2. 14 patients were assigned to stage V of CKD 
group with eGFR < 15 mL/min/1.73 m2 (Tab. 1). 
The data presented in table I showed that the 
subgroups under study displayed statistically significant 
differences in all essential considered parameters except 
the diastolic blood pressure.
Each of the study groups I–V (depending on the 
stage of chronic kidney disease) were divided into 
two subgroups: the study subjects with diabetes and 
hypertension (subgroup a) and the study subjects with 
hypertension without diabetes (subgroup b). Table 2 
presents anthropometric parameters and blood pres-
sure values regarding the entire group of patients di-
vided into subgroups according to the stage of chronic 
kidney disease.
The subgroups under study did not significantly 
differ statistically among one another, except for the 
group IIIa and group Ib, which differed significantly 
in such parameters as age, body weight and BMI. The 
above-studied subgroups did not differ statistically in 
terms of blood pressure measured on admission. 
Measurement of the body weight and height was 
performed using a mechanical physician scale with 
height rod of AED company. 24-hour automatic blood 
pressure measurement was performed with a regis-
trar — Oscar 2 of Oxford company, model Oscar 2, 
number 97-0012-00. Blood pressure was measured 
every 20 minutes during the day (6.00–22.00) and every 
30 minutes at night. The limit of normal for average 
blood pressure when awake was set at the value of 
135/85 mm Hg and for average blood pressure when 
asleep was 120/80 mm Hg [11]. The concentration of 
creatinine in the blood was examined in all the stud-
ied subjects and it was performed with Jaffe kinetic 
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method. Subsequently, the creatinine clearance was 
defined, using the Cockroft-Gault equation [12]. 
Statistical analysis
Normally distributed data were presented as mean 
± standard deviation. Data deviating from a normal 
distribution and ordinal data were given as median 
and upper and lower quantiles. The quality data were 
displayed in the form of percentage; the assessment of 
the distribution normality of the obtained results was 
performed against the Shapiro-Wilk test. The variables, 
which were considered to be statistically significant 
parameters, displayed the significance level p, which 
was less than 0.05. The calculations were performed 
using the Statistica 8.0 version PL and Excel Microsoft 
Office Package programs.
Permission to conduct research
In the light of the Law of 5 December 1996 on 
the professions of physicians and dentists (i.e. Journal 
of Laws of 2011 No. 277, item 1634 as amended) the 
aforementioned study is not a medical experiment and 
does not require the assessment of the Bioethics Com-
mittee of SMU in Katowice (03.05.2014).
Table 1. Anthropometric parameters and readings of blood pressure on admission to hospital in respective subgroups 
of patients divided according to the stages of chronic kidney disease
Groups of the 
study subjects 
depending on 
the stage of 
chronic kidney 
disease 
Age  
[years]
Height  
[m]
Weight  
[kg]
BMI  
[kg/m2]
Average  
duration of 
hypertension 
[years]
Average  
duration  
of systolic 
blood  
pressure  
[mm Hg]
Average  
duration  
of diastolic 
blood  
pressure  
[mm Hg]
I 52.6 ± 13.73 1.66 ± 0.09 85.43 ± 22.09 32.36 ± 12.81 10.78 ± 8.86 150 ± 25 87 ± 14
II 61.69 ± 14.83 1.63 ± 0.09 84.58 ± 19.68 31.10 ± 7.54 13.98 ± 8.89 158 ± 31 91 ± 23
III 64.82 ± 14.23 1.64 ± 0.09 83.74 ± 16.4 31.04 ± 5.70 13.89 ± 7.83 150 ± 25 89 ± 20
IV 65.96 ± 14.7 1.64 ± 0.07 82.57 ± 16.41 30.67 ± 5.81 16.80 ± 8.71 142 ± 28 82 ± 15
V 58.28 ± 12.14 1.68 ± 0.04 75.6 ± 10.99 26.61 ± 4.36 18.14 ± 11.07 153 ± 29 84 ± 12
Statistical 
significance 
of differences 
(ANOVA test)
0.0001 0.0001 0.0001 0.0001 0.0001 0.0281 NS
Table 2. Anthropometric parameters and readings of blood pressure of the study subjects in the previously named subgroups
Stage of chronic 
kidney disease 
(CKD) of the  
a and b  
subgroup
Age  
[years]
Height  
[m]
Weight  
[kg]
BMI  
[kg/m2]
Average  
duration of 
hypertension 
[years]
Average  
duration of 
systolic blood 
pressure  
[mm Hg]
Average  
diastolic  
blood  
pressure  
[mm Hg]
Ia, n = 45 55.80 ± 11.34 1.65 ± 0.09 87.23 ± 22.8 33.31 ± 13.24 11.82 ± 8.39 151 ± 23 86 ± 10
Ib, n = 11 39.54 ± 15.57 1.69 ± 0.08 71.4 ± 14.5 39.54 ± 15.57 6.45 ± 8.92 147 ± 33 90 ± 22
IIa, n = 43 63.44 ± 13.12 1.63 ± 0.09 88.05 ± 20.53 31.78 ± 8.12 16.27 ± 9.65 159 ± 28 88 ± 11
IIb, n = 26 58.8 ± 17.26 1.61 ± 0.10 76.14 ± 14.9 58.8 ± 17.26 10.04 ± 5.67 154 ± 35 98 ± 35
IIIa, n = 63 68.80 ± 11.02 1.60 ± 0.09 88.18 ± 17.19 32.68 ± 5.8 14.76 ± 8.19 151 ± 24 88 ± 19
IIIb, n = 46 59.24 ± 16.35 1.64 ± 0.1 78.26 ± 13.76 59.24 ± 16.35 12.6 ± 7.20 147 ± 27 90 ± 21
Iva, n = 34 68.32 ± 13.24 1.63 ± 0.07 79.9 ± 15.66 30.00 ± 6.21 18.11 ± 8.63 144 ± 30 82 ± 15
IVb, n = 18 61.6 ± 16.60 1.67 ± 0.07 89.25 ± 17.36 61.5 ± 16.60 14.17 ± 7.20 139 ± 22 82 ± 15
Va, n = 3 58.33 ± 8.02 1.7 ± 0.04 80 ± 13 27.68 ± 4.36 9 ± 8.9 150 ± 28 82 ± 13
Vb, n = 11 58.27 ± 13.3 1.68 ± 0.04 74.5 ± 12.36 58.27 ± 13.3 20.63 ± 8.5 154 ± 27 85 ± 13
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Results
Daily (average, maximum, minimum) values of 
systolic and diastolic blood pressure in the entire group 
of the study subjects, including the patients with dia-
betes and hypertension and patients with hypertension 
without diabetes (Tab. 3). 
The conducted research showed no differences be-
tween the daily systolic blood pressure in patients with 
diabetes and hypertension and patients with hyperten-
sion without diabetes. Daily diastolic blood pressure 
was significantly higher in patients with hypertension 
without diabetes. No differences were demonstrated 
both in systolic and diastolic blood pressure when 
measured during the day. At night the systolic blood 
pressure was higher in patients with diabetes than 
without diabetes.
The provided criteria recommendations for the 
daily blood pressure control were not met by 33.33% 
patients in the entire group, 36.88% in the group of 
patients with diabetes and hypertension and 31.81% 
in the group of patients with hypertension without 
diabetes. Substantially statistically significant difference 
between the patients with hypertension with diabetes 
and without diabetes was shown (p < 0.001). 
Daily (average, maximum, minimum) values of 
systolic and diastolic blood pressure in the group of 
the study subjects divided according to the stages of 
chronic kidney disease (Tab. 4). 
No significant differences were demonstrated in 
the values of systolic and diastolic blood pressure when 
measured over the period of 24 hours and during the 
day between the patients with hypertension without 
diabetes at different stages of CKD.
Daily (average, maximum, minimum) values of 
systolic and diastolic blood pressure in the entire group 
of patients with diabetes depending on the develop-
ment of chronic kidney disease stage in them (Tab. 5).
No significant differences were demonstrated in 
the values of systolic blood pressure over the period 
of 24 hours, during the day and at night in the studied 
groups of patients with diabetes and hypertension de-
pending on the stage of chronic kidney disease.
Daily (average, maximum, minimum) values of sys-
tolic and diastolic blood pressure in the entire group of 
patients with hypertension without diabetes depending 
on the stage of chronic kidney disease (Tab. 6).
No significant differences were demonstrated in 
the values of systolic blood pressure over the period 
Table 4. Daily values of systolic and diastolic blood pressure in the entire group of the study subjects divided according 
to the stages of chronic kidney disease
Parameter Stage 1 CKD 
n = 58
Stage 2 CKD 
n = 68
Stage 3 CKD 
n = 108
Stage 4 CKD 
n = 52
Stage 5 CKD 
n = 14
Statistical significance  
of differences between  
the subgroups under study
SBPaverage 139 ± 20 138 ± 25 138 ± 18 140 ± 20 143 ± 19 NS
SBPmax 175 ± 23 169 ± 15 172 ± 23 175 ± 24 166 ± 20 NS
SBPmin 107 ± 17 108 ± 19 107 ± 18 107 ± 20 121 ± 20 NS
DBPaverage 78 ± 12 77 ± 13 76 ± 11 76 ± 13 78 ± 12 NS
DBPmax 109 ± 26 105 ± 23 104 ± 18 101 ± 21 100 ± 17 NS
DBPmin 55 ± 10 54 ± 11 54 ± 10 56 ± 12 61 ± 13 NS
Table 3. Daily values of systolic and diastolic blood pressure and pulse pressure in the entire group of the study subjects 
and in patients with and without diabetes
Parameter The studied group 
n = 300
Patients with  
diabetes n = 188
Patients without  
diabetes n = 112
Statistical significance of differences  
between patients with and without diabetes
SBPaverage 139 ± 21 140 ± 20 138 ± 21 NS
SBPmax 197 ± 20 177 ± 22 210 ± 23 0.014
SBPmin 108 ± 18 108 ± 17 109 ± 21 NS
DBPaverage 77 ± 12 76 ± 11 79 ± 14 0.026
DBPmax 105 ± 21 106 ± 22 103 ± 20 NS
DBPmin 55 ± 11 54 ± 10 57 ± 13 0.003
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of 24 hours, during the day and at night in the studied 
groups of patients with hypertension depending on the 
stage of chronic kidney disease. 
Differences between the data presented in Table 5 
and Table 6 are non-statistically significant. 
The percentage of patients whose blood pressure 
was not controlled properly in both the entire study 
group and individual subgroups, over the period of 
24 hours as well as during the day and at night is 
presented in Table 7.
The percentage of patients not obtaining proper 
blood pressure control over the period of 24 hours as 
well as during the day and at night was significantly 
higher in patients without diabetes (Tab. 8). 
The number of patients whose daily blood pres-
sure does not equalize over the period of 24 hours, 
during day and at night increases together with the 
stage of CKD.
The percentage of patients not obtaining proper 
blood pressure control in individual subgroups, both 
over the period of 24 hours as well as during the day 
and at night and the statistical significance of differ-
ences between the subgroups of patients with diabe-
tes and hypertension and patients with hypertension 
Table 5. Daily values of systolic and diastolic blood pressure in the group of patients with diabetes and hypertension 
depending on the stage chronic kidney disease
Parameter Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Statistical significance  
of differences between  
the subgroups under study
SBPaverage 140 ± 20 139 ± 27 140 ± 20 140 ± 15 140 ± 23 NS
SBPmax 176 ± 24 181 ± 22 177 ± 23 178 ± 21 166 ± 28 NS
SBPmin 108 ± 18 109 ± 18 109 ± 18 106 ± 16 121 ± 7 NS
DBPaverage 80 ± 11 76 ± 12 75 ± 11 74 ± 11 78 ± 13 NS
DBPmax 113 ± 28 106 ± 20 105 ± 22 100 ± 21 99 ± 12 NS
DBPmin 56 ± 10 53 ± 11 53 ± 9 55 ± 11 56 ± 8 NS
Table 6. Daily values of systolic and diastolic blood pressure in patients with hypertension without diabetes depending 
on the stage of chronic kidney disease
Parameter Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Statistical significance  
of differences between  
the subgroups under study 
SBPaverage 136 ± 24 138 ± 24 136 ± 18 141 ± 29 147 ± 19 NS
SBPmax 173 ± 24 173 ± 24 168 ± 24 171 ± 31 167 ± 21 NS
SBPmin 105 ± 16 109 ± 23 105 ± 18 111 ± 26 125 ± 20 NS
DBPaverage 76 ± 17 80 ± 15 79 ± 13 81 ± 15 80 ± 12 NS
DBPmax 98 ± 20 104 ± 28 105 ± 14 106 ± 23 102 ± 20 NS
DBPmin 55 ± 13 58 ± 13 55 ± 13 60 ± 14 64 ± 14 NS
Table 7. The percentage of patients not obtaining proper blood pressure control in both the entire study group and 
individual subgroups, over the period of 24 hours as well as during the day and at night
Parameter Patients with 
diabetes
Patients  
without  
diabetes
Patients with 
stage 1 CKD
Patients with 
stage 2 CKD
Patients with 
stage 3 CKD
Patients with 
stage 4 CKD
Patients with 
stage 5 CKD
Over the period 
of 24 hours
36.88 31.81 22.75 33.82 42.22 43.07 50.00
During the day 42.29 40.90 29.65 35.29 42.40 42.69 50.00
At night 46.00 40.90 34.82 48.52 39.81 54.23 52.85
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without diabetes, depending on the stage of chronic 
kidney disease (Tab. 9).
Diabetics with 1, 2 or 4 stage of chronic kidney 
disease obtained worse control of blood pressure than 
patients without diabetes.
Discussion
The conducted research showed that the values of 
blood pressure in patients with diabetes and without 
diabetes were significantly higher than the values con-
sidered to be normal, despite the applied treatment. 
This suggests that the anti-hypertensive treatment 
that was carried out in the study participants was not 
conducted aggressively enough. Both in patients with 
diabetes and in patients without diabetes hypertension 
requires appropriate treatment. This is associated with 
the behavioral treatement (diet and physical effort) and 
pharmacological one. Behavioral treatment is difficult 
as, according to dietary guidelines, all patients with 
hypertension should cut down on salt intake. There are 
many products with high salt content on the market 
and it is very difficult to eliminate them. Moreover, in 
patients with hypertension it is usually required to use 
several anti-hypertensive agents, the selection of which 
is also not simple. 
Unfortunately, the lack of blood pressure control 
increases the risk of complications (especially cardio-
vascular diseases) [13]. 
Significantly more patients with diabetes and hy-
pertension, in comparison to the number of patients 
with hypertension and without diabetes did not obtain 
correct blood pressure values. Patients with diabetes are 
exposed to very high risk of complications, particularly 
cardiovascular complications, in comparison to patients 
without diabetes. Polish Scientific Associations (PTNT) 
[14], and European Scientific Associations (ESH) [15] 
publish guidelines considering the proper treatment 
in order to control the patients’ blood pressure. As it 
turns out, the studies that we conducted show that 
it is often impossible to control the blood pressure 
to a satisfactory degree. It applies, to a much greater 
extent, to patients with diabetes and hypertension. 
How then can this fact be explained? It seems very 
likely that in patients with diabetes the progression of 
Table 9. The percentage of patients not obtaining proper blood pressure control in individual subgroups, both over the 
period of 24 hours as well as during the day and at night
Parameter Patients with  
stage 1 CKD
Patients with  
stage 2 CKD
Patients with  
stage 3 CKD
Patients with  
stage 4 CKD
Patients with  
stage 5 CKD
Over the period of 24 hours
Patients with diabetes 33.33 32.55 22.22 37.64 53.33
Patients without diabetes 36.36 34.61 21.73 33.33 54.54
During the day
Patients with diabetes 42.22 34.88 25.39 29.41 53.33
Patients without diabetes 36.36 34.61 31.30 38.88 54.54
At night
Patients with diabetes 48.88 53.48 41.26 51.17 53.33
Patients without diabetes 36.36 38.46 36.95 40.00 45.45
Parameter Statistical significance of differences in subgroups of patients  
with and without diabetes depending on the stage of chronic kidney disease
Stage 1 Stage 2 Stage 3 Stage 4 Stage 5
Over the period of 24 hours NS NS NS NS NS
During the day NS NS NS NS NS
At night p < 0.05 p < 0.05 NS p < 0.05 NS
Table 8. Statistical significance of differences between 
the group of patients with hypertension and diabetes 
and without diabetes who do not obtain proper blood 
pressure control
Parameter Statistical significance of differences  
between the group of patients  
with hypertension and diabetes  
and without diabetes
Over the period  
of 24 hours
p < 0.05
During the day p < 0.05
At night p < 0.001
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atherosclerotic lesions is much faster than in patients 
with hypertension and without diabetes. The progres-
sion of atherosclerotic lesions leads to stiffness of vessel 
walls. Vessels become less sensitive to drugs which are 
to lower the blood pressure. It is supported by the fact 
that in both groups of patients the time from the mo-
ment of hypertension diagnosis was very similar. This 
is extremely unfavourable for the prognosis, especially 
in patients with diabetes.
There were no significant differences in the values 
of the systolic and diastolic blood pressure and the 
blood pressure measured around the clock, during 
the day and at night in patients with diabetes and 
hypertension at different stages of CKD and in patients 
without diabetes with hypertension at different stages 
of CKD. The number of patients whose daily blood pres-
sure is not controlled properly during day and at night 
increases together with the stage of CKD.
The blood pressure usually increases with the 
development of renal failure [8]. Interestingly, in both 
groups of subjects, both in patients with diabetes 
and hypertension and in patients with hypertension 
but not suffering from diabetes, the systolic and dias-
tolic blood pressure and the blood pressure measured 
around the clock, during the day and at night, did not 
increase significantly together with the progression of 
CKD. It can also confirm the fact that the patients were 
aware of their disease and complications and, there-
fore, remained under medical supervision. Moreover, 
they took the prescribed anti-hypertensive medicines. 
However, this is only partially true. As it was shown in 
the conducted research, the number of patients whose 
blood pressure was not controlled properly increased 
significantly, according to the statistics. Interestingly, 
it concerned both daily pressure, and the pressure 
during the day and at night. The average increase in 
blood pressure is a very important factor which strains 
cardiovascular system. Thus, despite the fact that, in 
general, there was no increase in average pressure in 
the individual stages of CKD, the blood pressure in 
some patients did increase. It suggests that the blood 
pressure of some patients, certainly strictly obeying 
the therapeutic recommendations (concerning both 
non-pharmaceutical — behavioural and pharmaceuti-
cal treatement) was better controlled and, therefore, 
not only reduced the risk of developing cardiovascular 
complications, but also slowed down the process of 
renal failure progression. However, the second part 
of the patients, unfortunately, did not obeyed the 
therapeutic recommendations or their attitude towards 
the proposed therapeutic recommendations was too 
liberal, which increased the risk of developing cardio-
vascular complications (related to both diabetes and 
hypertension) and increased the risk of fast renal failure 
progression.
It should be also noted that the growing number 
of patients (in both groups) with worse blood pressure 
control, especially at night, is particularly dangerous. 
Deterioration in the blood pressure control is a very 
important factor that deteriorates the quality of life, 
and reduces the patients’ life expectancy.
There are also differences in values of systolic and 
diastolic blood pressure, during the day and at night 
between patients with diabetes and hypertension at 
different stages of CKD. During the measurement of 
blood pressure during the day in patients with hyper-
tension but without diabetes with stages 2 (p = 0.048) 
and 3 (p = 0.018) of CKD the values of diastolic blood 
pressure were significantly higher than in patients with 
diabetes and hypertension. During the day, however, 
the values of pulse pressure in patients with stage 2 
(p = 0.006) and 3 (p = 0.035) of CKD in patients with 
diabetes and hypertension were significantly higher 
than in patients with hypertension but without diabe-
tes. Finally, the values of systolic blood pressure in the 
patients with diabetes and hypertension with stage 2 
of CKD (p = 0.049) were significantly higher than in 
patients with hypertension but without diabetes. Also, 
the values of pulse pressure in patients with diabetes 
and hypertension with stage 2 (p = 0.023) and stage 3 
(p = 0.003) of CKD were significantly higher than in 
patients with hypertension but without diabetes. The 
percentage of patients whose blood pressure was not 
properly controlled during the day and at night was 
significantly higher in patients with diabetes and hy-
pertension than in patients without diabetes. And the 
percentage of patients whose blood pressure was not 
properly controlled at night was significantly higher 
in patients with diabetes and hypertension than in 
patients without diabetes with stage 1 (p < 0.05), 2 
(p < 0.05) and 3 (p < 0.05) of CKD.
Thus, the blood pressure of the patients with 
diabetes and hypertension and patients with hyperten-
sion but without diabetes is, at first glance, controlled 
similarly at various stages of CKD. However, this is not 
the whole truth. As it was shown in the above descrip-
tion, the values of diastolic pressure during the day 
are higher in patients with hypertension but without 
diabetes at stage 3 and 4 of CKD, and the patients with 
hypertension and diabetes have significantly higher val-
ues of systolic blood pressure at stage 2 of CKD. Higher 
values of systolic blood pressure are associated with 
worse prognosis in patients with diabetes and hyper-
tension compared with patients without diabetes. As 
already noted, this indicates the significant progression 
of the atherosclerotic lesions in the blood vessels, and 
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thus the loss of elasticity of blood vessels. Blood vessels 
which are damaged by atherosclerotic lesions lead to 
the increased risk of complications related to heart and 
brain as well as to peripheral vessels. Interestingly, this 
applies only to patients with stage 2 and 3 of CKD. This 
does not apply to patients with stage 4 and 5 of CKD. 
This suggests that the progression of the disease at 
more advanced stages of renal failure is not dependent 
on the cause leading to the disease. It is similar in each 
patient. What is worse, it is irreversible. One practical 
observation may be drawn that patients with diabetes 
and hypertension should undergo the most intensive 
treatment up to the stage 3 of CKD. During this period, 
it is still possible to obtain the effects of approximated 
prognosis observed in patients with hypertension and 
without diabetes. In stages 4 and 5 irrespective of the 
cause (diabetes, hypertension) the therapeutic effect 
is similar. Unfortunately, these stages (stage 4 and 5 of 
CKD) display a significant deterioration in the quality 
of life and a substantial decrease in life expectancy.
Limitations of the study
The obtained research results present numerous 
cognitive and practical values. The conclusion which 
may be drawn from the research suggests that the 
results were influenced by many different factors. 
Particular attention should be paid to it. The critical 
remarks concerning the research listed below.
Selection of the study group 
Patients for the study were qualified following the 
sequence of their admission to the ward and obtaining 
their consent to be included in the study. The selection 
method of the study group seemed to be the best of 
all possible. Unfortunately, some patients, usually in 
worse clinical condition, did not grant their consent to 
be considered in the study. In this case the obtained 
result are the results displayed in patients with a bet-
ter prognosis and in this case the patients with worse 
prognosis were not included in the study. This could 
to some extent affect the results obtained.
Determination of creatinine clearance 
The Cockroft-Gault equation was used to de-
termine the creatinine clearance. It was the most 
practical one. However, the Cockroft-Gault equation 
proves to be proper to determine creatinine clearance 
in patients with good renal function. In patients with 
poor renal function this formula may slightly fail. In 
such case it is better to use MDRD formula or a dif-
ferent. This could generate some irregularities when 
assigning the patients to relevant groups according 
to the stage of CKD. 
Determination of daily blood pressure  
measurement
Daily blood pressure measurement was taken in all 
subjects. The measurement began in the next morning 
in case of the patients admitted in the morning; the 
measurement was taken in the morning in case the 
patients admitted in the evening or at night. This could 
have had an impact on the achieved study results.
Causes of hypertension
Causes of hypertensions were not indicated in 
the subjects. It is conceivable that some patients suf-
fered from secondary hypertension that had not been 
diagnosed earlier.
Treatment of hypertension
During daily blood pressure measurement, anti-
hypertensive medicines were taken by the patients who 
had also taken them before the measurement. Natu-
rally, the medicines had an impact on blood pressure 
measurements. In addition, the patients took different 
anti-hypertensive medicines with different pharmacoki-
netics and different duration of action. This could have 
a considerable impact on the achieved study results. 
Age and sex of subjects
The subjects’ age or sex did not have an impact on 
the achieved study results. This affects data interpreta-
tion to some extent. 
Creatinine clearance in subjects
All subjects were divided into groups depending of 
creatinine clearance. Unfortunately, the patient group 
with low creatinine clearance (< 15 mL/min/1.73 m2) 
featured the lowest number of members. In this case, 
the result achieved in one person could have an effect 
on the results of the entire group. The group should 
have more patients in further studies.
Conclusions
1. The blood pressure of patients with diabetes and 
hypertension is controlled to a significantly lesser 
extent (over the period of 24 hours, during the 
day and at night) in relation to patients with hy-
pertension without diabetes. 
2. The increasing degree of renal failure affects the 
increase in the number of patients with diabetes 
and hypertension as well as patients with hyper-
tension without diabetes whose blood pressure is 
not controlled properly, in particular the patients 
with diabetes and hypertension.
3. In order to prevent or delay the diabetes and hy-
pertension complication development it is neces-
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sary, to modify the anti-hypertensive treatment in 
rational but rather aggressive manner, especially 
in patients with diabetes to achieve the desired 
therapeutic objective.
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